|
Aug 1
|
Exact Sciences expands partnership with Humana to improve colorectal cancer screening
|
|
Jul 31
|
Will Exact Sciences Corporation (EXAS) Continue to Penetrate the Market with Its Cologuard Test?
|
|
Jul 31
|
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test
|
|
Jul 30
|
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jul 29
|
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
|
|
Jul 28
|
KROS vs. EXAS: Which Stock Should Value Investors Buy Now?
|
|
Jul 25
|
HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now?
|
|
Jul 25
|
3 Reasons EXAS is Risky and 1 Stock to Buy Instead
|
|
Jul 24
|
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
|
|
Jul 24
|
SubjectWell Appoints Veteran Healthcare Finance Leader Karl Stubelis as Chief Financial Officer
|
|
Jul 18
|
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know
|
|
Jul 16
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 30
|
Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth
|
|
Jun 27
|
Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care
|
|
Jun 11
|
High Growth Tech Stocks In The US To Watch This June 2025
|
|
Apr 11
|
2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution
|
|
Apr 7
|
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
|
|
Mar 28
|
High Growth Tech Stocks To Watch In The US March 2025
|
|
Mar 27
|
Should You Retain Exact Sciences Stock in Your Portfolio Now?
|
|
Mar 26
|
2 Small-Cap Stocks on Our Watchlist and 1 to Ignore
|